Crinetics Pharmaceuticals, Inc. has grown revenue 18% a year over three years and 155% a year over five. Revenue growth, 3-year annual rate: +18% (Biotechnology median +21%). Revenue growth, 5-year rate: +155%, growth has slowed since the five-year average. Years of annual history on file: 10, FY2016 to FY2025, as filed.

CRNXCrinetics Pharmaceuticals, Inc.

HealthcareUSD

$34.99

$26.8552 weeks$84.85

Is it growing?

Is CRNX growing?

Crinetics Pharmaceuticals, Inc. has grown revenue 18% a year over three years and 155% a year over five.

+18%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +155%
Revenue growth, 5-year rate · +18% over three · growth has slowed since the five-year average
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed

Details›